LYMPHOMA, MYELOMA AND GENOMICS
Professor Dipti Talaulikar
Senior Consultant in Clinical and Laboratory Haematologist,
Canberra Health Services, Australia &
ANU School of Medicine and Psychology, The Australian National University
Canberra, Australia
RESEARCHER PROFILE
Filmed in Canberra, Australia | November 2025
Professor Dipti Talaulikar is a clinical and laboratory haematologist with expertise in genomics, working at Canberra Health Services, and Professor at ANU. She has a clinical and research interest in lymphoma, myeloma and genomics, and has authored close to 100 peer reviewed papers, including several clinical guidelines that have had a significant impact on clinical practice.
Professor Talaulikar is an inclusive and innovative educator, having been involved with teaching medical students since the inception of the ANU Medical School, and has won 5 awards including the Vice Chancellor awards for teaching and education.
Her conviction, that knowledge has to be linked with community work, has led her to develop The Link program at ANU, with a focus on sharing knowledge across boundaries. She is passionate about gender equity and has developed the Link and Grow Mentoring Program for diverse women in health and medicine.
She is the President branch of ASMOF (Australian Salaried Medical Officers Federation) and the chair of the Gender Equity Group in Federal ASMOF.
Source: Supplied
https://orcid.org/0000-0001-6766-8345
-
Hormone receptor positive breast cancer and therapy resistance
Prof Elgene Lim is a medical oncologist at St Vincent’s Hospital and Head of the Connie Johnson Breast Cancer Research Lab at the Garvan Institute. Following his PhD at the Walter & Eliza Hall Institute where he identified the aberrant cells in carriers of the BRCA1 mutant gene, a hereditary breast cancer syndrome as the culprit cells giving rise to breast cancer, he furthered his research and clinical training at the Dana-Farber Cancer Institute and Harvard Medical School. He was awarded the National Breast Cancer Foundation Practitioner Fellowship in 2014 and returned from Boston to Australia. In 2017, he was awarded the inaugural National Breast Cancer Foundation Endowed Chair, and subsequently appointed the Principal Cancer Theme Lead at UNSW.
-
Outcomes of Corneal Allergenic Intrastromal Ring Segment (CAIRS) Surgery
Dr David Gunn is an ophthalmologist specialising in cornea, cataract, and refractive surgery at the Queensland Eye Institute and Focus Vision in Brisbane, Queensland. His journey into ophthalmology began during medical school, inspired by a mentor. His current research examines outcomes for patients undergoing Corneal Allergenic Intrastromal Ring Segment (CAIRS) surgery.
-
Therapies for chronic myeloid leukaemia
Professor Tim Hughes is an international expert in the biology and treatment of leukaemia. He led the establishment of the molecular response criteria that are used world-wide to measure response in chronic myeloid leukaemia (CML) and has led many of the key Global and National trials. His group has successfully developed predictive bioassays and molecular targets that influence the way CML patients are managed world-wide. He has published over 350 papers that have been cited over 65,000 times.
